Toward the realization of the Pharmaceutical Manufacturers Association of Japan Industry Vision 2035
The Pharmaceutical Manufacturers Association of Japan Industry Vision 2035
Toward the realization of
About the Pharmaceutical Manufacturers Association of Japan Industry Vision 2035
The Pharmaceutical Manufacturers Association of Japan (PAPMA) has set forth " Drug Discovery Innovation for Japan and the World " in its "PAPMA Industry Vision 2035" and is working toward the realization of this vision by focusing on the three pillars of Innovation, Access, and Trust.
Initiatives of each committee - Interview with committee chairpersons
-
Code Compliance
Promotion Committee
Chair Ouchi -
Product Information Outline Review Committee
Chairperson Mr. Kondo -
Industrial Policy Committee
Chairperson Mr . Iwashita -
Distribution Optimization Committee
Kumagai, Chairperson -
Drug Evaluation Committee
Chairperson Mr. Nakaji -
Quality Committee
Chairperson Mr. Kawashima -
Biopharmaceuticals Committee
Mr. Kurazazi, Chair -
Pharmaceutical Affairs Committee
Kashiwatani, Chair -
Intellectual Property Committee
Chair Okumura -
Research and Development Committee
Tsukahara, Chair -
International Committee
Chairperson Murakami -
Public Relations Committee
Chair Tada -
Patient Organization Collaboration Promotion Committee
Misawa Chair -
ICH Project
Chair Yokota -
Pharmaceutical Consultation Response Study Group
Chairperson Mr. Wakasugi -
Environmental Issues Study Group
Arima, Chairperson
Pharmaceutical Cooperative Co-creation Meeting
On July 25, 2025, the first "Co-creation Meeting" in the history of the Pharmaceutical Manufacturers Association of Japan (PMAJ) was held. 16 committee chairpersons, PMAJ executives and secretariat members gathered to discuss and share knee-deep in efforts to realize the "Industrial Vision 2035" and Action Plan. Under the leadership of Chairperson Asuka Miyabashira, the meeting served as an important milestone for the Pharmaceutical Manufacturers Association of Japan (PMAJ) to move forward as a united body.
